Table 8 Secondary outcomes among patients receiving warfarin compared between UMC and PLAC
Secondary outcomes | Total n (%) | UMC n (%) | PLAC n (%) | p-value |
|---|---|---|---|---|
Bleeding episodes | 118(22.5) | 89(25.4) | 29(16.6) | 0.715 |
Thromboembolic episodes | 23(4.4) | 15(4.3) | 8(4.6) | 0.435 |
Emergency department visits | 69(13.1) | 64(18.3) | 5(2.9) | 0.003 |
Hospitalization | 76(14.5) | 62(17.7) | 14(8.0) | 0.469 |